[Combination of antibiotics with analgesic and antipyretic substances (author's transl)]. 1979

G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici

1. We suggest a combination of analgesic and antipyretic medicaments in medical treatments with antibiotics. Thus, the antibiotic is increased and microorganisms, resistant to antibiotics, are converted into sensitive forms. 2. The results of the in vitro used method (diffusion plate test) are in accordance with the results obtained using these combinations in therapy. 3. This method should not be applied to strains that are sufficiently sensitive to antibiotics, since the results would be contrary to the afore mentioned. 4. The effects of a combination are additionally synergistic in the case of strains originally sensitive. 5. This method offers great possibilities for multiplying treatments with antibiotics. We recommend to give standardized combinations of antibiotics with analgesic and antipyretic medicaments per os.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic

Related Publications

G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
November 1951, Annales pharmaceutiques francaises,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
April 1979, Masui. The Japanese journal of anesthesiology,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
March 1979, Masui. The Japanese journal of anesthesiology,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
March 1982, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
July 1980, Casopis lekaru ceskych,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
July 1977, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
May 2004, Human & experimental toxicology,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
January 1981, Arzneimittel-Forschung,
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
February 1962, Clinical medicine (Northfield, Ill.),
G Pasăre, and V Pasăre, and N Eftimescu, and M Ivan, and A Milici
January 1985, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!